Marvell Technology, Inc.

NasdaqGS:MRVL Stock Report

Mkt Cap: US$39.3b

We’ve recently updated our valuation analysis.

Marvell Technology Valuation

Is MRVL undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for MRVL?

Other financial metrics that can be useful for relative valuation.

MRVL key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue7.4x
Enterprise Value/EBITDA24x
PEG Ration/a

Price to Sales Ratio vs Peers

How does MRVL's PS Ratio compare to its peers?

The above table shows the PS ratio for MRVL vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPSEstimated GrowthMarket Cap
Peer Average4.6x
GFS GLOBALFOUNDRIES
4.4x6.6%US$34.4b
MCHP Microchip Technology
5.8x1.9%US$44.6b
ON ON Semiconductor
4.2x2.7%US$33.7b
NXPI NXP Semiconductors
3.8x3.1%US$50.3b
MRVL Marvell Technology
6.7x10.7%US$39.3b

Price-To-Sales vs Peers: MRVL is expensive based on its Price-To-Sales Ratio (6.7x) compared to the peer average (4.6x).


Price to Earnings Ratio vs Industry

How does MRVL's PE Ratio compare vs other companies in the US Semiconductor Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a16.1%
n/an/an/a

Price-To-Sales vs Industry: MRVL is expensive based on its Price-To-Sales Ratio (6.7x) compared to the US Semiconductor industry average (3.8x)


Price to Sales Ratio vs Fair Ratio

What is MRVL's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

MRVL PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio6.7x
Fair PS Ratio5.1x

Price-To-Sales vs Fair Ratio: MRVL is expensive based on its Price-To-Sales Ratio (6.7x) compared to the estimated Fair Price-To-Sales Ratio (5.1x).


Share Price vs Fair Value

What is the Fair Price of MRVL when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: MRVL ($46.12) is trading below our estimate of fair value ($57.25)

Significantly Below Fair Value: MRVL is trading below fair value, but not by a significant amount.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst MRVL forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$46.12
US$61.41
+33.1%
23.8%US$125.00US$41.00n/a29
Jan ’24US$37.04
US$62.46
+68.6%
22.9%US$125.00US$41.00n/a30
Dec ’23US$45.40
US$70.27
+54.8%
20.4%US$125.00US$52.00n/a30
Nov ’23US$39.74
US$71.88
+80.9%
20.8%US$125.00US$52.00n/a30
Oct ’23US$42.91
US$73.88
+72.2%
18.5%US$125.00US$58.00n/a30
Sep ’23US$45.97
US$74.57
+62.2%
18.4%US$125.00US$58.00n/a29
Aug ’23US$55.33
US$77.52
+40.1%
21.4%US$125.00US$54.34n/a29
Jul ’23US$42.55
US$84.17
+97.8%
17.5%US$125.00US$60.00n/a29
Jun ’23US$58.04
US$85.99
+48.2%
15.6%US$125.00US$62.00n/a29
May ’23US$58.08
US$93.59
+61.1%
14.3%US$125.00US$62.00n/a28
Apr ’23US$71.07
US$96.78
+36.2%
14.2%US$125.00US$62.00n/a27
Mar ’23US$64.95
US$101.26
+55.9%
11.8%US$120.00US$62.00n/a27
Feb ’23US$72.42
US$101.26
+39.8%
11.8%US$120.00US$62.00US$46.1227
Jan ’23US$87.49
US$100.04
+14.3%
11.3%US$120.00US$62.00US$37.0427
Dec ’22US$70.95
US$77.62
+9.4%
14.5%US$100.00US$50.00US$45.4026
Nov ’22US$68.96
US$74.15
+7.5%
12.8%US$100.00US$50.00US$39.7426
Oct ’22US$59.83
US$69.73
+16.5%
12.1%US$85.00US$40.00US$42.9126
Sep ’22US$60.72
US$68.92
+13.5%
12.4%US$85.00US$40.00US$45.9725
Aug ’22US$60.51
US$60.04
-0.8%
12.5%US$74.00US$40.00US$55.3325
Jul ’22US$57.39
US$58.68
+2.2%
10.9%US$70.00US$40.00US$42.5525
Jun ’22US$47.75
US$54.00
+13.1%
11.9%US$64.00US$40.00US$58.0415
May ’22US$45.21
US$54.67
+20.9%
12.7%US$64.00US$40.00US$58.0812
Apr ’22US$49.66
US$53.56
+7.8%
12.9%US$64.00US$35.00US$71.0727
Mar ’22US$49.52
US$52.85
+6.7%
14.9%US$64.00US$30.00US$64.9526
Feb ’22US$52.87
US$52.42
-0.8%
15.5%US$64.00US$30.00US$72.4226

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies